Security key
68622P109
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)
CUSIP: 68622P109
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 105,956,500
- Total 13F shares
- 50,638,764
- Share change
- +3,182,999
- Total reported value
- $465,880,631
- Put/Call ratio
- 86%
- Price per share
- $9.20
- Number of holders
- 91
- Value change
- +$34,655,080
- Number of buys
- 54
- Number of sells
- 37
Report period
Q4 2023
Institutions
91
Top holders
10
ORIC full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Oric Pharmaceuticals, Inc. SEC filings
Oric Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68622P109
Recent filing periods:
Top shareholders of ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nextech Invest Ltd. |
13F
|
Company |
4%
|
4,285,714
|
$25,928,570 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.5%
|
3,732,606
|
$22,582,268 | — | 30 Sep 2023 | |
| Column Group LLC |
13F
|
Company |
3.4%
|
3,568,181
|
$21,587,495 | — | 30 Sep 2023 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.3%
|
3,479,289
|
$21,049,699 | — | 30 Sep 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
3.2%
|
3,418,068
|
$20,679,311 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
3%
|
3,132,194
|
$18,949,774 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
2,588,869
|
$15,662,657 | — | 30 Sep 2023 | |
| Prosight Management, LP |
13F
|
Company |
2.4%
|
2,579,802
|
$15,607,802 | — | 30 Sep 2023 | |
| Venrock Adviser, LLC |
13F
|
Company |
2%
|
2,142,856
|
$12,964,279 | — | 30 Sep 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2%
|
2,142,855
|
$12,964,273 | — | 30 Sep 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
1.6%
|
1,732,571
|
$10,482,055 | — | 30 Sep 2023 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.6%
|
1,649,956
|
$9,982,234 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,163,760
|
$7,040,748 | — | 30 Sep 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,123,345
|
$6,796,237 | — | 30 Sep 2023 | |
| Invus Financial Advisors, LLC |
13F
|
Company |
0.95%
|
1,007,575
|
$6,095,829 | — | 30 Sep 2023 | |
| Euclidean Capital LLC |
13F
|
Company |
0.93%
|
989,410
|
$5,985,931 | — | 30 Sep 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.84%
|
893,668
|
$5,406,691 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.77%
|
820,447
|
$4,964,330 | — | 30 Sep 2023 | |
| Vivo Capital, LLC |
13F
|
Company |
0.73%
|
777,944
|
$4,706,561 | — | 30 Sep 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.71%
|
750,411
|
$4,539,986 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.68%
|
719,014
|
$4,350,035 | — | 30 Sep 2023 | |
| Sloan Kettering Cancer Center Memorial |
13F
|
Individual |
0.57%
|
602,272
|
$3,643,746 | — | 30 Sep 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.4%
|
418,706
|
$2,533,171 | — | 30 Sep 2023 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.36%
|
384,793
|
$2,327,998 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
379,800
|
$2,298,000 | — | 30 Sep 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.33%
|
351,502
|
$2,126,587 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
342,900
|
$2,074,545 | — | 30 Sep 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
341,537
|
$2,066,299 | — | 30 Sep 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.29%
|
307,479
|
$1,860,248 | — | 30 Sep 2023 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.19%
|
204,500
|
$1,237,225 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.16%
|
169,019
|
$1,022,565 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
145,007
|
$877,292 | — | 30 Sep 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
143,943
|
$870,855 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.13%
|
133,106
|
$805,291 | — | 30 Sep 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.12%
|
124,850
|
$755,343 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
124,191
|
$751,355 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
114,650
|
$693,633 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
105,882
|
$640,586 | — | 30 Sep 2023 | |
| M&T BANK CORP |
13F
|
Company |
0.07%
|
70,964
|
$428,981 | — | 30 Sep 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
58,581
|
$354,406 | — | 30 Sep 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
48,700
|
$294,635 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
48,156
|
$291,344 | — | 30 Sep 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.04%
|
45,115
|
$274,000 | — | 30 Sep 2023 | |
| Atom Investors LP |
13F
|
Company |
0.03%
|
34,241
|
$207,158 | — | 30 Sep 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.03%
|
34,018
|
$206,000 | — | 30 Sep 2023 | |
| Pale Fire Capital SE |
13F
|
Company |
0.03%
|
33,055
|
$199,983 | — | 30 Sep 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.03%
|
32,436
|
$196,238 | — | 30 Sep 2023 | |
| Jump Financial, LLC |
13F
|
Company |
0.03%
|
32,149
|
$194,501 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
31,114
|
$188,240 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
26,809
|
$162,195 | — | 30 Sep 2023 |
Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q4 2023
As of 31 Dec 2023,
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,638,764 shares.
The largest 10 holders included
FMR LLC, Nextech Invest Ltd., ALKEON CAPITAL MANAGEMENT LLC, Column Group LLC, EcoR1 Capital, LLC, BlackRock Inc., VR Adviser, LLC, VANGUARD GROUP INC, Frazier Life Sciences Management, L.P., and ArrowMark Colorado Holdings LLC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
89
Q4 2023 holders
91
Holder diff
2
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.